Interleukin-1 Receptor Antagonist: A Promising Cytosine In Human Squamous Epithelial Cell Carcinoma
SSRN Electronic Journal2022
Citations Over Time
Related Papers
- → Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration*(2017)96 cited
- → Studying the Pharmacokinetics of Interleukin-1RA Mutants(2019)1 cited
- → Activity of an Interleukin 1 Receptor Antagonist in Rabbit Models of Uveitis(1992)58 cited
- → Role of Interleukin-1/Interleukin-1 Receptor Antagonist Family of Cytokines in Long-Term Continuous Glucose Monitoring In Vivo(2013)8 cited
- Correlation between osteoarthritis and interleukin-1 receptor antagonist(2007)